Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study
Academic Article
Publication Date:
2020
Short description:
Real-time assessment of COVID-19 prevalence among multiple sclerosis patients: a multicenter European study / Dalla Costa, G., Leocani, L., Montalban, X., Guerrero, A.I., Sorensen, P.S., Magyari, M., Dobson, R.J.B., Cummins, N., Narayan, V.A., Hotopf, M., Comi, G.. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - 41:7(2020), pp. 1647-1650. [10.1007/s10072-020-04519-x]
abstract:
We assessed the prevalence and impact of COVID-19 among multiple sclerosis (MS) patients across Europe by leveraging participant data collected as part of the ongoing EU IMI2 RADAR-CNS major programme aimed at finding new ways of monitoring neurological disorders using wearable devices and smartphone technology. In the present study, 399 patients of RADAR-MS have been included (mean age 43.9 years, 60.7% females) with 87/399 patients (21.8%) reporting major symptoms suggestive of COVID-19. A trend for an increased risk of COVID-19 symptoms under alemtuzumab and cladribine treatments in comparison to injectables was observed. Remote monitoring technologies may support health authorities in monitoring and containing the ongoing pandemic.
Iris type:
1.1 Articolo in rivista
Keywords:
COVID-19; Multiple Sclerosis; Remote monitoring technologies; Adult; Alemtuzumab; Coronavirus Infections; Europe; Female; Humans; Longitudinal Studies; Male; Middle Aged; Multiple Sclerosis; Pandemics; Pneumonia, Viral; Prevalence; Betacoronavirus
List of contributors:
Dalla Costa, G.; Leocani, L.; Montalban, X.; Guerrero, A. I.; Sorensen, P. S.; Magyari, M.; Dobson, R. J. B.; Cummins, N.; Narayan, V. A.; Hotopf, M.; Comi, G.
Published in: